Your search returned 2 results.

Results
	1.	Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204. [electronic resource] by Landry, Jerome C Feng, Yang Prabhu, Roshan S Cohen, Steven J Staley, Charles A Whittington, Richard Sigurdson, Elin Ruth Nimeiri, Halla Verma, Udit Benson, Al Bowen Producer: 20160315 In: The oncologist vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204. [electronic resource] by Landry, Jerome C Feng, Yang Cohen, Steven J Staley, Charles A Whittington, Richard Sigurdson, Elin Ruth Nimeiri, Halla Verma, Udit Prabhu, Roshan S Benson, Al Bowen Producer: 20130913 In: Cancer vol. 119 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search